Manufacturer
Bayer
The FDA has removed the Adempas REMS requirements.
Please print and complete the form below. Once completed, fax to the number indicated on the form.
Getting your patient started on PAH therapy
Pulmonary arterial hypertension (PAH) is characterized as WHO Group 1. The diagnosis of PAH may require confirmation with a complete right heart catherization. The current hemodynamic definition of PAH is a mean pulmonary artery pressure greater than 25mmHg; a pulmonary capillary wedge pressure, or left ventricular end-diastolic pressure less than or equal to 15mmHg; and a pulmonary vascular resistance greater than 3 Wood units.
Manufacturer link below for additional drug information